BAYN - Bay National Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.0495
0.0000 (0.00%)
At close: 9:31AM EDT
Stock chart is not supported by your current browser
Previous Close0.0495
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume366
Market Cap106,672
Beta-0.85
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Stocks set to open in the red, judge dismantles Trump's plan to deport Dreamers
    Yahoo Finance5 months ago

    Stocks set to open in the red, judge dismantles Trump's plan to deport Dreamers

    Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.

  • Reuters7 months ago

    EU mergers and takeovers (Nov 3)

    BRUSSELS, Nov 3 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS -- France's CNP Assurances, Australian ...

  • What Trump has done to lower the ‘RIPOFF DRUG PRICES’ he’s decrying
    Yahoo Finance9 months ago

    What Trump has done to lower the ‘RIPOFF DRUG PRICES’ he’s decrying

    Trump has decried these price hikes since the campaign. President Donald Trump blasted Merck CEO Kenneth C. Frazier on Monday morning after Frazier announced he was leaving the President’s manufacturing council following Trump’s equivocal response to the neo-Nazi and white nationalist rally in Charlottesville, Virginia. In March, Democratic Representatives Elijah Cummings (MD) and Peter Welch (VT) met with Trump to discuss their bill that would help lower prescription drug prices by allowing regulated drug importation and Medicare’s ability to negotiate wholesale prices for wholesale drugs, instead of retail prices.

  • TheStreet.com10 months ago

    Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day

    With Calyxt, perhaps you truly can have your cake and eat it too.

  • Bayer CEO 'Very Confident' About Closing Monsanto Deal
    Bloomberg Video24 days ago

    Bayer CEO 'Very Confident' About Closing Monsanto Deal

    May.03 -- Werner Baumann, chief executive officer at Bayer, discusses earnings, a pending deal with Monsanto and the overall outlook for the company. He speaks with Matt Miller and Guy Johnson on “Bloomberg Markets: European Open.”

  • Bayer Clears EU Hurdle for Monsanto Deal
    Bloomberg Video2 months ago

    Bayer Clears EU Hurdle for Monsanto Deal

    Mar.21 -- Bloomberg's Aoife White discusses Bayer's pledge to sell BASF seeds, pesticides and digital agriculture technology as a bargaining chip to buy Monsanto. She speaks on "Bloomberg Markets: European Close."

  • Bayer Said to Face U.S. Antitrust Hurdles in Monsanto Bid
    Bloomberg Video2 months ago

    Bayer Said to Face U.S. Antitrust Hurdles in Monsanto Bid

    Mar.15 -- Bloomberg's Ed Hammond discusses Bayer's plan to takeover Monsanto. Two people familiar with the matter say U.S. antitrust officials are worried the merger could hurt competition. Hammond speaks with Vonnie Quinn and Mark Barton on "Bloomberg Markets: European Close."

  • Bayer May Sell More Businesses Amid Monsanto Deal Delays
    Bloomberg Video3 months ago

    Bayer May Sell More Businesses Amid Monsanto Deal Delays

    Feb.28 -- Bayer says it may sell more businesses in addition to its seeds unit as its existing units struggle and the process of closing its $66 billion acquisition of Monsanto drags on. Bayer Chief Executive Officer Werner Baumann discusses potential divestitures with Bloomberg's Francine Lacqua and Tom Keene on "Bloomberg Surveillance."

  • Bayer Betting Plants Can Fertilize Themselves
    Bloomberg Video7 months ago

    Bayer Betting Plants Can Fertilize Themselves

    Oct.26 -- Bayer AG is teaming up with Ginkgo Bioworks, a Boston-based biotechnology company, on a record $100-million wager on farming technology. The seeds for bets like these are sewn at the Bayer Lifescience Center in Cambridge, Massachusetts. Bloomberg's Anne Mostue reports.

  • BASF Agrees to $7B Bayer Deal
    Bloomberg Video7 months ago

    BASF Agrees to $7B Bayer Deal

    Oct.13 -- BASF has agreed to buy part of Bayer's seed and herbicide business for $7B, helping to clear the way for Bayer's $66B acquisition of Monsanto. Bloomberg's Phil Serafino reports on "Bloomberg Daybreak: Europe."